31 results on '"Chatwal, Monica"'
Search Results
2. Ethics of Patient-Clinician Boundaries in Oncology: Communication Strategies for Promoting Clinician Well-Being and Quality Patient Care
3. 662 Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma
4. Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma.
5. A phase IIa study of sequential ("first strike, second strike") therapies, modeled on evolutionary dynamics of anthropocene extinctions, for high-risk metastatic castration-sensitive prostate cancer.
6. Early results from a phase 1, multicenter trial of PSCA-specific GoCAR T cells (BPX-601) in patients with metastatic castration-resistant prostate cancer (mCRPC).
7. Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma.
8. Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
9. A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer
10. Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
11. Colonic Adenocarcinoma with Plasmacytoid Feature: Histopathology and Molecular Characteristics of a Rare Neoplasm with an Unusual Presentation
12. Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform
13. Pathology of Seminoma Coinciding With Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
14. Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO’s Clinician Well-Being Taskforce
15. Outcomes and Evolving Treatment Paradigms for Small Cell Carcinoma of the Bladder
16. Building resilient oncologists: A feasibility study of a resiliency curriculum for hematology oncology fellows.
17. A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology
18. Mindful fellows: Study results from a pilot wellness curriculum in hematology oncology.
19. Combination chemotherapy and immunotherapy in metastatic non-small cell lung cancer: a setback for personalized medicine?
20. Initial tumor flare or mixed tumor response following single PD-1 vs. dual PD-1/CTLA-4 blockade in non-small cell lung cancer (NSCLC).
21. A feasibility study to examine the role of a mindfulness-based wellness curriculum for early clinical trainees.
22. Phase I/II study of nivolumab and ipilimumab combined with nintedanib in advanced NSCLC.
23. Malignant mesothelioma clinical trial combines immunotherapy drugs
24. Anti PD-L1 combined with other agents in non-small cell lung cancer: combinations with non-immuno-oncology agents
25. Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
26. Empathirises
27. Outcomes for Myeloma in the Era of Lenalidomide Maintenance Are Not Different Among Ethnic Groups Following Autologous Transplant
28. Racial Disparity in Patients with Multiple Myeloma Are Blunted in the Era Novel Therapies
29. Artist’s Statement
30. Artist's Statement: Empathirises.
31. Fear of Saying No (FOSNO): Setting Boundaries With Our Patients and Ourselves.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.